• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/29

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

29 Cards in this Set

  • Front
  • Back
What are the important inhibitors of intestinal cholesterol absorption?
Ezetimibe
Describe ezetimibe
-A specific inhibitor of intestinal absorption of cholesterol and plant sterols
-Reduces LDL levels
-Useful in monotherapy for patients who cannot tolerate statins or in combination with statins
-Reduces LDL by about 18%
-Increased HDL 3%
-No significant effect on trigluceride levels
-No evidence that it reduces CHD risk
Describe the mechanism of ezetimibe
-Interferes with cholesterol absorption in the small intestine
-The molecular target is a specific brush border protein that is involved in cholesterol transport for the intestinal lumen into the mucosal cell
-Reduced cholesterol absorption leads to a reduced hepatic cholesterol pool
-To try and restore hepatic cholesterol homeostasis, hepatic LDL receptor activity increases and clearance of LDL from plasma is accelerated
How do you treat patients with a zero-cholesterol diet
-Used Ezetimibe
-Most of the cholesterol within the intestinal lumen is of biliary origin
-Blocking intestinal absorption of cholesterol can be expected to reduce plasma LDL levels in zero-cholesterol diet patients
Describe the effect of Ezetimibe on non-LDL substances
-Does not cause a generalized fat malabsorption
-No effect on intenstinal absoprtion of triglyceride, vitamin A, vitamin D, bile acid, ethinylestradiol, or progesterone
Describe what happens to ezetimibe after ingestion
-It is converted to its glucuronide, which is more potent at inhibiting cholesterol absoprtion
-Ezetimibe glucuronide is targeted to its pharmacologic site of action by an enterohepatic circualtion and by a propensity to concentrate at the intestinal mucosal cell brush border
Describe the excretion of ezetimibe
-Predominantly through the intestine
-No more than 11% by the kidneys
Describe the systemic exposure of ezetimibe
Very low
Describe the side effects of ezetimibe
-Well tolerated
-No reported side effects
What are the important Fibric Acide Derivatives?
Gemfibrozil
Fenofibrate
Fenofibric Acid
Clofibrate
Describe the mechanism of Fibric Acid Derivatives
-Mediated by interactions with the peroxisome proliferator receptor alpha (PPAR-alpha)
-Some of the most important effects are
i. Increased synthesis of lipoprotein lipaase
ii. Increased synthesis of apolipoproteins AI and AII, the major proteins of HDL
iii. Increased syntehsis of the ABCA1 transporter, which promotes cholesterol efflux from cells to HDL in the process of HDL assembly
iv. Reduction of apoC-III, an inhibitor of lipoprotein lipase
v. Decreased expression of NPC1K1, a critical protein for cholesterol absoprtion (and also the pharmacological target of ezetimibe)
What is the main pharmacological effect of fibric acid derivatives?
To reduce levels of VLDL by enhancing its intravascular catabolism through increased lipoprotein lipase activity
Describe the effects of Fibric Acid Derivatives
-Increases levels of lipoprotein lipase
-Reduces LDL by ~10%
-May increase LDL in hypertriglyceridemic patients
Describe the drug-drug interactions of Fibric Acid Derivatives
-Potentiates the effects of warfarin by displacing it from the binding sites of albumin
Describe the side effects of Fibric Acid Derivatives
-GI disturbance
-Weight gain
-Decreased libido
-Drowsiness
-Skin rashes
-Alopecia
-Moderate and transient serum transaminase elevations occur but do not indicate hepatic injury
-Drugs increase lithogenicity of bile
-Usage assocaited with increased incidence of choleslithiasis and cholecystitis
-Acute myositus and cardiac ventricular irritability (rare)
Which Fibric Acid Derivatives are prefered for use with statins?
-Fenofibrate and Fenofibric acid
-Less potential for causing drug drug interactions
What are the side effects of clofibrate?
-Cardiac arrhythmias
-Cardiomegaly
-Increased angina pectoris
-Intermittent claudication
-Thromboembolic phenomena
Which Fibric Acid Derivatives should be used in patients who have CHD?
-Fenofibrate
-Gemfibrozil
Who should be treated with fibrin acid drugs?
1) Those with low HDL levels who have diabetes or the metabolic syndrome

2) Those with very high triglyceride levels

3) Those with dysbetalipiproteinemia
Describe Long-Chain Omega-3 Fatty Acids
-Present in fish oils
-Potent in lowering plasma VLDL levels of normal and hypertriglyceridemic patients
-Have beneficial effects on CHD and arrhythmic sudden death at much lower levels than required for lipid lowering treatment
Describe the mechanism of Omega 3 Fatty Acids
-Primary effect is to reduce levels of sterol receptor element binding proteins (SREBPs)
-This decreases lipogenesis and increases intracellular degradation of apoB within the hepatocyte
-This causes marked reduction in the secretion of VLDL
Describe the effect of Omega 3 Fatty Acids on Cholesterol levels
-Have little to no effect on LDL levels
-Cause a small reduction in HDL levels
-May increase LDL levels in hypertriglyceridemic persons
Describe the Statin-Bile Acid Sequestrant Combination
-Statin + Bile acid sequestrant is effective
-Activity is synergistic, Statin block the increased hepatic cholesterogenesis that occurs when a bile acid sequestrant is used
What combinations of drugs are used to reduce LDL
-Statin+Bile Acid Sequestrant
-Statin+Ezetimibe
-Statin+Nicotinic Acid
-Statin+Fibric Acid Derivative
-Bile acid sequestrant+Nicotinic Acid
-Statin+Bile Acid Sequestrant+Nicotinic Acid
Describe the Statin-Nicotinic acid combination
-Highly effective
-Combination leads to a small increase in myositis risk
Describe the Statin-Fibric Acid Derivative combination
Gemfibrozil
-Increased incidence of myosistis
-Less effective in reducing LDL levels

-Usually done with fenofibrate or fenofibric acid
Describe the Bile Acid Sequestrant + Nicotinic Acid combination
-Bile acid sequestrants enhance clearance of LDL
-Nicotinic acid decreases production of VLDL
-Combination gives additive results
-Nicotonic acid attenuates increase in VLDL levels seen in patietns treated with bile acid sequestrants
What are the most effective medications for reducing triglyceride levels?
-Omega 3 Fatty Acids
-Nicotinic Acid
-Fibrinc acid Derivatives
What drugs increase HDL levels and by how much?
-Nicotinic Acid (25-50%)
-Fibric acid drugs (10%, but greater in hypertriglyceridemic persons)
-Statins (5-10%)
-Bile acid sequestrants (2%)